ACS Early Rule Out Pathway Tool

Clinical calculation support · Verify results before clinical use

Enter clinical and assay values

Use values and thresholds validated for the specific high-sensitivity troponin assay used by your laboratory.

0 h / 1 h
Used to flag the ≥3-hour condition in this configurable aid.
Enter the reported result using the same unit as all thresholds.
Use the actual sample interval required by your local pathway.
Reset Fields

Clinical context

High-sensitivity cardiac troponin (hs-cTn) is the preferred biomarker for evaluating suspected acute myocardial infarction. Validated clinical decision pathways use assay-specific concentrations and changes over a defined sampling interval, interpreted alongside symptoms and ECG findings.

This page compares the entered values with thresholds supplied by the user. It is a configurable screening aid, not a validated standalone 0/1-hour algorithm, and it must not be used by itself to discharge a patient or diagnose myocardial infarction.

Important interpretation points

  • A value above the 99th-percentile upper reference limit indicates myocardial injury, but does not by itself establish myocardial infarction.
  • Acute myocardial infarction requires a rise and/or fall in cardiac troponin with at least one value above the 99th percentile plus clinical evidence of acute myocardial ischaemia.
  • Assay-specific algorithms have distinct baseline and delta thresholds. A generic threshold combination cannot reproduce all validated pathways.
  • Use the ECG, clinical presentation, haemodynamic status, symptom recurrence, comorbidities, and local protocol. Persistent suspicion may require further sampling even after a low initial result.
  • Do not delay urgent management for suspected STEMI or an unstable patient while awaiting this calculation.

References

Rao SV, O'Donoghue ML, Ruel M, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. Journal of the American College of Cardiology. 2025. Official guideline publication
Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. European Heart Journal. 2023;44(38):3720–3826. doi:10.1093/eurheartj/ehad191. Read the ESC guideline
Clinical disclaimer: This tool provides a threshold-based summary of entered values and is not a substitute for a locally validated assay-specific clinical decision pathway, ECG interpretation, or clinician judgement. Do not use its output alone to rule in or rule out acute coronary syndrome, determine disposition, or guide treatment.